BUSINESS● LOWAug 11 · Aug 11, 2026, 3:30 AM
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
prnewswire.com · United States
Aureka Biotechnologies has secured $100 million in Series B funding to develop a biological world model for drug discovery. This investment will support advanced scientific research in pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
WORLD4h agoThese baby names dominated the 1990s in the United States: Is yours on the list?ClarínPOLITICS13h agoHow Trump’s diesel deal with Russia will impact the United States and UkraineDW News [en]MILITARY13h agoStarlink signal cut: Ukraine under pressure from the United StatesLe Figaro InternationalPOLITICS21h agoOfficial and confirmed | The United States can deport foreigners who do not appear at the hearing with Form I-862Clarín
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowFormula 1: Can Kagame's financial gamble pay off?Jeune AfriqueBUSINESS20m agoUK economy grew 0.1% in August, beating expectationsCNBC